N(ε)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status

Por Ahmed, Khaled A., Muniandy, Sekaran, Ismail, Ikram S.
Publicado em 2009

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects

Por Al-Hamodi, Zaid, Ismail, Ikram S, Saif-Ali, Riyadh, Ahmed, Khaled A, Muniandy, Sekaran
Publicado em 2011

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects

Por Al-Hamodi, Zaid, Saif-Ali, Riyadh, Ismail, Ikram S., Ahmed, Khaled A., Muniandy, Sekaran
Publicado em 2012

Wound Healing Activities of Rafflesia Hasseltii Extract in Rats

Por Abdulla, Mahmood A., Ahmed, Khaled A., Ali, Hapipah M., Noor, Suzita M., Ismail, Salmah
Publicado em 2009

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects

Por Al-Hamodi, Zaid H., Saif-Ali, Riyadh, Ismail, Ikram S., Ahmed, Khaled A., Muniandy, Sekaran
Publicado em 2012